Scientists test timing tweak in lung cancer fight
NCT ID NCT03307759
Summary
This small, early-stage study aimed to find the safest and most effective way to combine two treatments for advanced lung cancer that has spread: a type of precise, high-dose radiation and an immunotherapy drug. Researchers tested whether giving the immunotherapy before or after the radiation worked better. The main goal was to check for serious side effects, and the study was stopped early after enrolling only 13 people.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peter MacCallum Cancer Centre
Melbourne, Victoria, 3000, Australia
Conditions
Explore the condition pages connected to this study.